News
Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc. February 21, 2012 | Press Release
Biotech Dealmaking Gets off to a Strong Start in 2012 February 01, 2012 | Press Release
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
See all News
News
Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc.
February 21, 2012Biotech Dealmaking Gets off to a Strong Start in 2012
February 01, 2012Burrill & Company Announces Close of Burrill Brazil Fund I
January 18, 2012See all News ›
Portfolio Company News
AliveCor Raises $3 Million Series A Equity Round
August 23, 2011Evolva completes Abunda acquisition
July 08, 2011Taiwan Liposome Company approved for public status registration
October 05, 2010See all Portfolio Company News ›
Events
BIO International Convention: The Partnering for Global Health Forum - Strategies for Engaging in Emerging Markets Session
June 27, 2011See all Events ›